Sanofi expands US vaccine venture in Covid-19 race | Malay Mail

📆 6/24/2020 2:42 AM
📰 malaymail

⏱ Reading Time:
21 sec. here
2 min. at publisher
📊 Quality Score:
News: 12%
Publisher: 86%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

PARIS, June 23 — French pharmaceutical giant Sanofi said today that it would invest US$425 million (RM1.8 billion) to expand its vaccine development venture with US start-up Translate Bio as they aim to find a Covid-19 vaccine by next year. The companies have been working together since 2018,...

In a statement, Sanofi said they have ‘multiple Covid-19 vaccine candidates’ in the works and hope to start a clinical trial with humans in the fourth quarter of this year. — Reuters pic

Their work has taken on greater urgency with the coronavirus pandemic, as pharma groups race to be the first to offer a vaccine to halt an outbreak that has killed nearly 470,000 people worldwide since December. Sanofi CEO Paul Hudson told journalists yesterday that his firm’s most promising Covid-19 treatment is “the only vaccine in the race which is offering a proven platform which works at scale.”

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Covid-19: US businesses in Malaysia adjusting, seizing opportunities | Malay MailKUALA LUMPUR, June 22 — United States-based companies in Malaysia have resumed operations and are adjusting to the— with a focus on mitigating the risks that emerged while driving efficiency and productivity. Chief Executive Officer (CEO) of the American Malaysian Chamber of Commerce (AMCHAM),...
Source: malaymail - 🏆 1. / 86 Read more »